Drug Database
Back to search

Belgium· BE-AMP-SAM389277-00

Teysuno 15 mg - 4.35 mg - 11.8 mg

A tegafur, kombinationen product containing gimeracil, registered in Belgium by Nordic Group. The same ATC class is registered in 9 of our 19 countries.

ATC L01BC53

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedTeysuno 15 mg - 4.35 mg - 11.8 mgATCL01BC53REGISTER NO.BE-AMP-SAM389277-00PACKS LISTED2CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about gimeracilAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Tegafur, kombinationen is registered in 9 of 19 countries.

Countries holding a registration under ATC L01BC53 (tegafur, kombinationen), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 6 of them publish a price we can compare per daily dose
Search tegafur, kombinationen products by name

Tegafur, kombinationen · ATC L01BC53

9 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Gimeracil
Manufacturer
Nordic Group
Country
Belgium (BE)
ATC code
L01BC53
ATC class
Tegafur, Kombinationen
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

1 priced
  • be_apb
    2968154
    EUR 353.49
  • be_apb
    7702160

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under L01BC53

Tegafur, kombinationen, as other registers publish it.

All tegafur, kombinationen products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b0267c60-20ad-4c64-a167-ce782a742af4
GET /v1/drugs/b0267c60-20ad-4c64-a167-ce782a742af4?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Capsule, hard",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Teysuno 15 mg - 4.35 mg - 11.8 mg",
  "name_fr": "Teysuno 15 mg - 4.35 mg - 11.8 mg",
  "name_nl": "Teysuno 15 mg - 4.35 mg - 11.8 mg",
  "amp_code": "SAM389277-00",
  "strengths": [
    "4.3500",
    "11.8000",
    "15.0000",
    "11.8000",
    "11.8000",
    "15.0000",
    "4.3500",
    "11.8000"
  ],
  "pack_count": 3,
  "substances": [
    "Gimeracil",
    "Oteracil Potassium",
    "Oteracil",
    "Tegafur",
    "Lactose Monohydrate",
    "Sodium Laurilsulfate"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Tegafur, Combinations",
  "authorisation_numbers": [
    "EU/1/11/669/002",
    "EU/1/11/669/001",
    "EU/1/11/669/005"
  ]
}
API referenceMCP serverPlans

See everything about tegafur, kombinationen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console